Professional Documents
Culture Documents
Stem Cells Market
Trends based on Primary
Industry Analysis
– Industry SWOT
– Primary Market Data of Markers Used to Characterize Different
Cellular Classes
– Publications Landscape
• Taken together, these data provide a backdrop for understanding
the stem cells marketplace as it exists today
• >$1 Billion in Product Sales Currently in
the Broader Cellular Therapy Marketplace
Currently
• 30 percent compound annual growth rate
• Product Classes Breakout
– Dermatologic/Wound Care
– Musculo‐skeletal
– Other Classes
GENengnews.com GENReports: Market & Tech Analysis, Produced by Enal Razvi, Ph.D. © 2013
Stem Cell Research Trends based on
Primary Market Research performed
by SELECTBIO
Market Penetrance of Various Vendors into
the Different Segments of the Stem Cells
Research Marketplace
100
Hepatocytes for Toxicity
90 Screening
90%
80%
70%
60%
50%
Height of Each Bar is Proportional to the Penetrance of the Given Marker
40% for Characterization of the Cell Type.
For Pluripotent Cells, the Most Penetrant Markers are Oct4 & Nanog
30%
20%
10%
0%
50%
40%
30%
20%
10%
0%
Height of Each Bar is Proportional to the Penetrance of the Given Marker for
Characterization of the Cell Type.
For MSCs, the Most-Penetrant Markers are: STRO-1, CD44, CD73, and CD105
GENengnews.com GENReports: Market & Tech Analysis, Produced by Enal Razvi, Ph.D. © 2013
Markers [Surface or Intracellular] Used
to Characterize Neural Stem Cells
(NSCs)
80%
70%
60%
50%
40%
30%
20%
10%
0%
Height of Each Bar is Proportional to the Penetrance of the Given Marker for
GENengnews.com
Characterization of the Cell Type.
GENReports: Market & Tech Analysis, Produced by Enal Razvi, Ph.D. © 2013
80%
70%
60%
50%
40%
30%
20%
10%
0%
CD34 CD45 CD59 CD133 Thy-1 CD38 c-Kit Lin ABCG2 Sca-1
Height of Each Bar is Proportional to the Penetrance of the Given Marker for
GENengnews.com
Characterization of the Cell Type.
GENReports: Market & Tech Analysis, Produced by Enal Razvi, Ph.D. © 2013
Clin. Heart
Epigenetics More
Trials Diseases
• Expansion of the Cellular Therapy Space
– CAGR @ 30%
• Increasing Number of Clinical Trials in the US and
EU
– 415 cellular therapy product trials under ATMP
guidelines in the EU
• Stem Cells Publications Space being Populated
Across Disease Classes
• Products for Stem Cell Research from Research
Product Vendors Proliferating Æ This space is
very fragmented and is ripe for consolidation
• This conference brings together researchers as well as clinicians involved in cellular
therapy
• Keynotes by CIRM and Clinician‐Scientists Æ Provide Trajectory of the Field, Regulatory
Trends, Opportunities for Entry, Status of Grants
• Focus on Adipose‐derived Stem Cells, Cord blood‐derived Stem Cells, Adult Stem Cells
• Clinical Practicum Presents Harvest of Adipose‐derived Stem Cells and SVF Preparation
• For more information to attend, exhibit or sponsor, please e‐mail: enal@selectbio.us